Pinnacle Associates Ltd. Has $1.18 Million Position in HCA Healthcare, Inc. (NYSE:HCA)

Pinnacle Associates Ltd. raised its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 1.4% in the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 3,403 shares of the company’s stock after acquiring an additional 48 shares during the period. Pinnacle Associates Ltd.’s holdings in HCA Healthcare were worth $1,176,000 at the end of the most recent quarter.

A number of other institutional investors also recently modified their holdings of the business. Brown Advisory Inc. lifted its stake in shares of HCA Healthcare by 53.9% in the 1st quarter. Brown Advisory Inc. now owns 4,630 shares of the company’s stock valued at $1,600,000 after acquiring an additional 1,622 shares during the last quarter. Farther Finance Advisors LLC boosted its position in shares of HCA Healthcare by 26.9% during the 1st quarter. Farther Finance Advisors LLC now owns 1,141 shares of the company’s stock valued at $395,000 after purchasing an additional 242 shares in the last quarter. GAMMA Investing LLC boosted its position in shares of HCA Healthcare by 17.6% during the 1st quarter. GAMMA Investing LLC now owns 4,931 shares of the company’s stock worth $1,704,000 after purchasing an additional 737 shares in the last quarter. Oppenheimer Asset Management Inc. grew its position in HCA Healthcare by 2.5% in the 1st quarter. Oppenheimer Asset Management Inc. now owns 4,314 shares of the company’s stock valued at $1,491,000 after purchasing an additional 105 shares during the period. Finally, Brighton Jones LLC bought a new position in shares of HCA Healthcare in the fourth quarter valued at approximately $1,021,000. Institutional investors own 62.73% of the company’s stock.

Analysts Set New Price Targets

HCA has been the subject of several research reports. Baird R W lowered shares of HCA Healthcare from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, April 15th. Robert W. Baird reissued a “neutral” rating and issued a $336.00 price target (down from $396.00) on shares of HCA Healthcare in a report on Tuesday, April 15th. Wall Street Zen raised shares of HCA Healthcare from a “hold” rating to a “buy” rating in a report on Saturday, July 5th. Truist Financial upped their price target on shares of HCA Healthcare from $390.00 to $415.00 and gave the company a “buy” rating in a research report on Wednesday, July 16th. Finally, Wells Fargo & Company upgraded HCA Healthcare from an “underweight” rating to an “equal weight” rating and boosted their price objective for the company from $320.00 to $385.00 in a research report on Thursday, May 29th. Eight research analysts have rated the stock with a hold rating, nine have given a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $399.46.

HCA Healthcare Stock Performance

HCA Healthcare stock opened at $334.26 on Monday. The company has a debt-to-equity ratio of 69.07, a quick ratio of 0.86 and a current ratio of 0.98. HCA Healthcare, Inc. has a fifty-two week low of $289.98 and a fifty-two week high of $417.14. The company has a 50 day moving average price of $373.81 and a 200-day moving average price of $346.16. The company has a market capitalization of $80.41 billion, a PE ratio of 14.05, a P/E/G ratio of 1.15 and a beta of 1.47.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings results on Friday, July 25th. The company reported $6.84 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $6.20 by $0.64. The firm had revenue of $18.61 billion for the quarter, compared to the consensus estimate of $18.49 billion. HCA Healthcare had a net margin of 8.21% and a negative return on equity of 7,363.11%. The firm’s quarterly revenue was up 6.4% compared to the same quarter last year. During the same period in the prior year, the firm posted $5.50 earnings per share. As a group, equities analysts forecast that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 30th. Shareholders of record on Tuesday, September 16th will be issued a $0.72 dividend. This represents a $2.88 dividend on an annualized basis and a yield of 0.86%. HCA Healthcare’s dividend payout ratio is currently 12.11%.

Insiders Place Their Bets

In other news, COO Jon M. Foster sold 15,698 shares of the firm’s stock in a transaction dated Tuesday, May 13th. The shares were sold at an average price of $369.32, for a total value of $5,797,585.36. Following the transaction, the chief operating officer directly owned 12,646 shares in the company, valued at approximately $4,670,420.72. This trade represents a 55.38% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. 1.30% of the stock is currently owned by corporate insiders.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.